Tower Research Capital (TRC)’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-444
| Closed | -$4.05K | – | 6157 |
|
|
2024
Q1 | $4.05K | Buy |
444
+15
| +3% | +$94 | ﹤0.01% | 4746 |
|
|
2023
Q4 | $2.46K | Sell |
429
-7
| -2% | -$46 | ﹤0.01% | 5215 |
|
|
2023
Q3 | $3.42K | Buy |
436
+231
| +113% | +$5.81K | ﹤0.01% | 5007 |
|
|
2023
Q2 | $10.9K | Buy |
205
+95
| +86% | +$6.18K | ﹤0.01% | 4046 |
|
|
2023
Q1 | $7K | Sell |
110
-126
| -53% | -$9.15K | ﹤0.01% | 4792 |
|
|
2022
Q4 | $9K | Buy |
236
+188
| +392% | +$11.2K | ﹤0.01% | 4313 |
|
|
2022
Q3 | $3K | Buy |
+48
| New | +$3.24K | ﹤0.01% | 5455 |
|
|
2022
Q2 | – | Sell |
-46
| Closed | -$6K | – | 6699 |
|
|
2022
Q1 | $6K | Buy |
46
+27
| +142% | +$2.79K | ﹤0.01% | 4959 |
|
|
2021
Q4 | $2K | Sell |
19
-42
| -69% | -$5.54K | ﹤0.01% | 5703 |
|
|
2021
Q3 | $9K | Buy |
+61
| New | +$10.2K | ﹤0.01% | 4483 |
|
|
2021
Q2 | – | Sell |
-177
| Closed | -$53K | – | 5966 |
|
|
2021
Q1 | $53K | Buy |
177
+130
| +277% | +$44K | ﹤0.01% | 3078 |
|
|
2020
Q4 | $7K | Buy |
47
+17
| +57% | +$2.58K | ﹤0.01% | 4513 |
|
|
2020
Q3 | $6K | Buy |
+30
| New | +$4.43K | ﹤0.01% | 4321 |
|
|
2016
Q2 | – | Hold |
0
| – | -$3K | – | 5108 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 3188 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 5183 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 3431 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 4112 |
|
|
2014
Q1 | – | Hold |
0
| – | -$3K | – | 5048 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 3884 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 4156 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 2837 |
|
Tower Research Capital (TRC)'s YTEN Position: Q2 2024 in Review
Tower Research Capital (TRC) sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q2 2024, closing a stake of 444 shares — an estimated $4.05K sold.
Tower Research Capital (TRC) first reported a position in YTEN in Q3 2020 and held it in 13 quarters. The position peaked at $53K in Q1 2021. 0 funds tracked by Wall St. Rank hold YTEN as of Q2 2024.
- Tower Research Capital (TRC) reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Tower Research Capital (TRC) sold 444 Yield10 Bioscience, Inc. Common Stock shares in Q2 2024, an estimated $4.05K.
- Tower Research Capital (TRC) first reported a position in Yield10 Bioscience, Inc. Common Stock in Q3 2020 and held it in 13 quarters.
- Tower Research Capital (TRC)'s Yield10 Bioscience, Inc. Common Stock position peaked at $53K in Q1 2021.
- 0 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q2 2024.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2024, filed 13 Aug 2024.